AstraZeneca COVID-19 vaccine trial continues despite Brazilian volunteer death

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.